ReviewCurrent osteoporosis reports2025
Inequities Across the Spectrum of Osteoporosis Care and Post-Fracture Management in Men.
Review in Current osteoporosis reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Male osteoporosis: pathophysiology, risk assessment, and evidence-based management.Turkish journal of medical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewSex specific differences in the determinants, occurrence, and distribution of osteoporosis and osteoporotic fractures play a pivotal role in the implementation of timely surveillance, prevention and effective treatment approaches. This review is aimed at synthesizing recently published scientific evidence on disparities in the epidemiology and management of osteoporosis and related fragility fractures in men. RECENT
findingsSeveral studies have identified race-, sex-, geographic-, socioeconomic-, and comorbidity-based disparities in osteoporosis care. Over the last decade, the awareness and imperative for identifying osteoporosis in men have increased. Nonetheless, the treatment gap is increasing and osteoporosis in men remains severely underappreciated and undertreated. Fewer studies in men have focused on the factors beyond osteoporosis awareness. Recent data of individuals aged 50 years and older show an alarmingly greater increase in hip fractures in men compared to women. This coupled with the existing knowledge of greater disability burden and excess mortality due to fragility fractures in men is a cause of public health concern. This review offers a comprehensive examination of widespread and profound disparities across the spectrum of osteoporosis care and post-fracture management in men and highlights the considerable health economic aspect of this burden. We call for targeted multifaceted interventions: develop novel methods to engage patients and health professionals, increase screening and treatment of osteoporosis in men, conduct epidemiological studies focused on disease phenotyping and risk factor assessment, studies on the identification of perceptions and barriers to effective screening and treatment, expansion and further evaluation of cost-effective therapies and primary prevention strategies for fractures, implementation of fracture liaison services to address the treatment gap in secondary prevention, and promote inclusivity in outcome studies and therapeutic trials. These interventions are paramount to reduce inequities in osteoporosis care and post-fracture care in men.
Indexed as
Identifiers
41148389What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.